Apatinib inhibits tumor progression and promotes antitumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma.

被引：0
|
作者：
Chi, Yanyan
Wang, Feng
Meng, Xiangrui
Shan, Zhengzheng
Sun, Yan
Fan, Qingxia
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15554
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma
    Chi, Yanyan
    Wang, Feng
    Zhang, Yana
    Shan, Zhengzheng
    Tao, Weili
    Lian, Yujin
    Xin, Dao
    Fan, Qingxia
    Sun, Yan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (07) : 1905 - 1917
  • [2] Chaetoglobosin E inhibits tumor growth and promotes the anti- tumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma by targeting PLK1
    Chen, Jin-Hua
    Guo, Qing-Feng
    Liu, Qiu-Ge
    He, Bao-Xia
    Song, Wen-Ping
    Yin, Zhen-Hua
    Li, Dong-Bei
    Chen, Lin
    Zhang, Wen-Zhou
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (22)
  • [3] Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma
    Chen, Miao-Fen
    Lu, Ming-Shian
    Hsieh, Ching-Chuan
    Chen, Wen-Cheng
    CELLULAR ONCOLOGY, 2021, 44 (02) : 373 - 384
  • [4] Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma
    Miao-Fen Chen
    Ming-Shian Lu
    Ching-Chuan Hsieh
    Wen-Cheng Chen
    Cellular Oncology, 2021, 44 : 373 - 384
  • [5] Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
    Li, Jianqiang
    Wang, Lifen
    ONCOTARGETS AND THERAPY, 2017, 10 : 3965 - 3969
  • [6] CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
    Chen, Yen-Hao
    Lu, Hung-, I
    Lo, Chien-Ming
    Li, Shau-Hsuan
    CANCERS, 2021, 13 (16)
  • [7] Safety and efficacy of conversion therapy for esophageal squamous cell carcinoma.
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Masashi
    Matsuda, Satoru
    Fukuda, Kazumasa
    Nakamura, Rieko
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 362 - 362
  • [8] Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma
    Xu, Jing
    Hu, Zhendong
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 17 - 22
  • [9] Autocrine CCL5 promotes tumor progression in esophageal squamous cell carcinoma in vitro
    Wu, Yi-Cheng
    Shen, Yung-Chi
    Chang, John Wen-Cheng
    Hsieh, Jia-Juan
    Chu, Yen
    Wang, Cheng-Hsu
    CYTOKINE, 2018, 110 : 94 - 103
  • [10] ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma
    Sun, Guiying
    Ye, Hua
    Liu, Huijuan
    Li, Tiandong
    Li, Jiaxin
    Zhang, Xiaoyue
    Cheng, Yifan
    Wang, Keyan
    Shi, Jianxiang
    Dai, Liping
    Wang, Peng
    CANCER SCIENCE, 2024, 115 (01) : 70 - 82
12345